As concerns over the devastating Ebola outbreak in Western Africa have spread across the world this week, one story continues to be underplayed amidst the outpouring of alarming reports. There was a non-FDA-approved antidote flown into Liberia that is being credited with the recoveries of the two infected U.S. missionaries—but that, under current standards, may […]
Read More ›
Arizona could becomethe latest state to allow those who are terminally ill to try experimental treatment not yet approved by the FDA. This “right to try” ballot initiative will be put before voters in November. If passed, Arizona would join Colorado, Louisiana and Missouri in allowing the practice, which has been compared to the film […]
Read More ›PBS speaks with family whose child could benefit from Right To Try Precautions buy cheap tadalafil may lead to severe hypotensive effects in patients were upset stomach and headaches. The VigRX Plus producer statements that the click description order cialis online remedies has a lot more added herbal and natural wonders in it to handle […]
Read More ›John Stossel joins Varney & Co. to discuss Right To Try laws.
Read More ›
Darcy Olsen, president of the Arizona-based Goldwater Institute, and Richard Garr, president ofNeuralstem, a biotech company, wrote “Right to Try experimental drugs” in USA Today (5/28/2014). They pointed out that “this year, more than 5,000 Americans will lose their battle with ALS, commonly known as Lou Gehrig’s disease.” Up until recently, there was no medicine […]
Read More ›Judge Andrew Napolitano gives his perspective on Right To Try laws.
Read More ›Alex Witt discusses Right To Try law in Colorado with doctor.
Read More ›
A new movement aims to make experimental drugs available to the terminally ill. They have to share more. That’s the general opinion about the rich these days, and it seems to apply in special force when it comes to a certain kind of rich: the rich involved in medical innovation. Sometimes the issue is simply […]
Read More ›
Arizona voters this fall will be asked to decide whether terminally-ill patients should have access to experimental drugs that have not yet been fully reviewed by the Food and Drug Administration. Pushed by the Goldwater Institute, the ballot measure in Arizona, along with bills in Colorado, Louisiana and Missouri, would give patients and their doctors […]
Read More ›